 antibiot therapi intra-abdomin sepsi elderli experi ticarcillin clavulan acid age major factor outcom patient intra-abdomin sepsi poor outcom patient number physiolog immunolog chang treatment intra-abdomin sepsi special risk elderli standard aminoglycosid substanti risk nephrotox elderli patient altern aminoglycoside-contain regimen desir intra-abdomin infect multipl pathogen aerob anaerob polymicrobi natur intra-abdomin sepsi antimicrobi chemotherapi effect broad rang organ past sever year host new antibiot use combin drug potenti aminoglycosid mani patient intra-abdomin sepsi agent ticarcillin clavulan potassium activ wide spectrum aerob anaerob pathogen prospect open label trial ticarcillin clavulan gentamicin clindamycin sampl size small meaning statist comparison efficaci safeti regimen effect gener prolong administr aminoglycosid treatment intra-abdomin sepsi elderli initi empir use aminoglycosid